Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **cytochrome P450 family enzymes involved in adrenal steroidogenesis** are a group of heme-containing monooxygenases that catalyze key steps in the biosynthesis of all major classes of steroid hormones from cholesterol. These include mitochondrial type I enzymes such as cholesterol side-chain cleavage enzyme (**CYP11A1**, also known as **P450scc**) and 11β-hydroxylase (**CYP11B1**), as well as endoplasmic reticulum-associated type II enzymes like 17α-hydroxylase/17,20 lyase (**CYP17A1**) and 21-hydroxylase (**CYP21A2**)[2][4]. Each enzyme has distinct substrate specificity and tissue distribution within the adrenal cortex. These proteins require electron transfer partners—ferredoxin reductase/ferredoxin for mitochondrial forms; NADPH-cytochrome P450 oxidoreductase for microsomal forms—to function properly[1][3]. Mutations or inhibition affecting these enzymes can result in various forms of congenital adrenal hyperplasia or other disorders involving impaired production or excess accumulation of corticosteroids and sex steroids. Drugs such as ketoconazole act by inhibiting several members within this group—most notably at the cholesterol side-chain cleavage step and at 11β-hydroxylation—leading to decreased cortisol synthesis with clinical implications both therapeutically and regarding safety monitoring[5]. Autoimmunity targeting specific cytochrome P450s is implicated in diseases like autoimmune polyendocrine syndrome type I (APS I) and Addison's disease; autoantibodies against these antigens serve both diagnostic and prognostic roles[6]. Note on specificity: The term provided refers collectively to several related but distinct gene products rather than one canonical protein target. For structured data purposes it is preferable to specify individual isoforms such as "Cholesterol side-chain cleavage enzyme (CYP11A1)" or "Steroid 21-hydroxylase (CYP21A2)" depending on context.
Inhibition of enzymatic activity leading to reduced synthesis of glucocorticoids and mineralocorticoids
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 enzyme involved in adrenal steroidogenesis (CYP (general family); specific enzymes include CYP11A1, CYP17A1, CYP21A2, etc.).